Ngoc T Ngo, PHARMD
Pharmacist · Milpitas
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Ngoc T Ngo’s office at (408) 262-9855 to ask if they take your plan before you enroll.
California Medical Board record
Licence C54818 · Cancelled
Licence status: Cancelled · since 2011 · Temple University School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$46,383
Pharmacies billed $46,383 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 210) in 2024. At or below the middle of the specialty; the typical pharmacist clinician is at 0%.
0 generic and 210 brand-name prescriptions · $46,383 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Arexvy | 74 | $21,588 | $292 |
| Shingrix | 56 | $13,479 | $211 |
| Abrysvo | 19 | $5,875 | $309 |
| Twinrix | 11 | $2,275 | $142 |
| Boostrix Tdap | 26 | $1,725 | $66 |
Year by year
| 2024 | 210 | 162 | 0% (0) | 100% | $46,383 |
| 2023 | 272 | 224 | 0% (0) | 99% | $69,415 |
| 2022 | 71 | 57 | 0% (0) | 100% | $11,917 |
| 2021 | 58 | 49 | 0% (0) | 100% | $9,255 |
| 2020 | 58 | 52 | 0% (0) | 100% | $9,400 |
| 2019 | 194 | 132 | 0% (0) | 100% | $28,927 |
| 2018 | 105 | 84 | 0% (0) | 100% | $15,506 |
| 2017 | 48 | 43 | 0% (0) | 98% | $6,231 |
| 2016 | 31 | 31 | 0% (0) | 100% | $4,206 |
| 2015 | 26 | 24 | 0% (0) | 100% | $4,510 |
| 2014 | 19 | 18 | 0% (0) | 100% | $3,026 |
| 2013 | 28 | 27 | 0% (0) | 100% | $4,702 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Arexvy | 154 | $48,162 | $313 |
| Shingrix | 89 | $18,886 | $212 |
| Boostrix Tdap | 22 | $1,513 | $69 |
2022: 2 drugs
| Shingrix | 55 | $10,603 | $193 |
| Boostrix Tdap | 11 | $705 | $64 |
2021: 2 drugs
| Shingrix | 45 | $8,370 | $186 |
| Boostrix Tdap | 12 | $756 | $63 |
2020: 1 drug
| Shingrix | 52 | $9,052 | $174 |
2019: 2 drugs
| Shingrix | 160 | $26,460 | $165 |
| Boostrix Tdap | 18 | $1,106 | $61 |
2018: 2 drugs
| Shingrix | 90 | $14,538 | $162 |
| Boostrix Tdap | 12 | $731 | $61 |
2017: 2 drugs
| Zostavax | 19 | $4,440 | $234 |
| Boostrix Tdap | 25 | $1,492 | $60 |
2016: 1 drug
| Zostavax | 15 | $3,235 | $216 |
2015: 1 drug
| Zostavax | 20 | $4,137 | $207 |
2014: 1 drug
| Zostavax | 14 | $2,725 | $195 |
2013: 1 drug
| Zostavax | 22 | $4,180 | $190 |
Professional record
- NPI
- 1154621019
- Licence
- CA 54818California C54818: Cancelled
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 183500000X (183500000X)
- Mailing address
- 555 E Calaveras Blvd, Milpitas, CA, 95035
- NPI first listed
- 2010-10-26
- NPI last updated
- 2010-10-26
This is when the NPI record was last certified, not a medical board exam.